ZONISAMIDE IMPROVES PARKINSONISM IN DEMENTIA WITH LEWY BODIES (DLB): A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY

被引：0
|
作者：
Hasegawa, K. [1 ]
Murata, M. [2 ]
Odawara, T. [3 ]
Kajiwara, R. [4 ]
Takeuchi, H. [5 ]
Maruyama, H. [6 ]
Kosaka, K. [7 ]
机构：
[1] Sagamihara Natl Hosp, Neurol, Sagamihara, Kanagawa, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Neurol, Kodaira, Tokyo, Japan
[3] Yokohama City Univ, Hlth Management Ctr, Yokohama, Kanagawa, Japan
[4] Sumitomo Dainippon Pharma Co Ltd, Clin Res, Tokyo, Japan
[5] Sumitomo Dainippon Pharma Co Ltd, Data Sci, Tokyo, Japan
[6] Sumitomo Dainippon Pharma Co Ltd, Med Affairs, Tokyo, Japan
[7] Clin Ian Ctr Minami, Yokohama, Kanagawa, Japan
来源：
PARKINSONISM & RELATED DISORDERS | 2018年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OP-5-11
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [1] Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 185 - 186
  • [2] Zonisamide improves Parkinsonism in patients with DLB: A double-blind randomized placebo-controlled study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Tamai, Y.
    Nakamura, M.
    Shimazu, R.
    Kosaka, K.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S427 - S427
  • [3] Zonisamide Improves Parkinsonism Without Psychiatric Deterioration in Patients with DLB: A Double-Blind Randomized Placebo-Controlled Study
    Odawara, Toshinari
    Murata, Miho
    Hasegawa, Kazuko
    Tamai, Yoichi
    Nakamura, Masatoshi
    Kosaka, Kenji
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (03): : S160 - S161
  • [4] Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
    Hasegawa, Kazuko
    Kochi, Kenji
    Maruyama, Hidenori
    Konishi, Osamu
    Toya, Shunji
    Odawara, Toshinari
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (02) : 627 - 637
  • [5] Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study
    Murata, Miho
    Odawara, Toshinari
    Hasegawa, Kazuko
    Iiyama, Sayaka
    Nakamura, Masatoshi
    Tagawa, Masaaki
    Kosaka, Kenji
    [J]. NEUROLOGY, 2018, 90 (08) : E664 - E672
  • [6] Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
    McKeith, I
    Del Ser, T
    Spano, P
    Emre, M
    Wesnes, K
    Anand, R
    Cicin-Sain, A
    Ferrara, R
    Spiegel, R
    [J]. LANCET, 2000, 356 (9247): : 2031 - 2036
  • [7] Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients
    Murata, M.
    Nakamura, M.
    Maruyama, H.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S437 - S437
  • [8] Zonisamide improves parkinsonism in DLB patients: A randomized phase 3 trial
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S8 - S9
  • [9] Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: A phase 3 randomized clinical trial
    Murata, Miho
    Odawara, Toshinari
    Hasegawa, Kazuko
    Kajiwara, Ritsuko
    Takeuchi, Hisao
    Tagawa, Masaaki
    Kosaka, Kenji
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 76 : 91 - 97
  • [10] Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
    Aarsland, Dag
    Ballard, Clive
    Walker, Zuzana
    Bostrom, Fredrik
    Alves, Guido
    Kossakowski, Katja
    Leroi, Iracema
    Pozo-Rodriguez, Francisco
    Minthon, Lennart
    Londos, Elisabet
    [J]. LANCET NEUROLOGY, 2009, 8 (07): : 613 - 618
12345